Smith Thomas B
- SEC CIK
- 0001748462
No open-market purchases or sales filed in the past year.
Current role at each company
- COLL Collegium Pharmaceutical, IncEVP and Chief Medical Officeras of Feb 12, 2026
- BDSI Biodelivery Sciences International IncChief Medical Officeras of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Thomas B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COLL Collegium Pharmaceutical, Inc
EVP and Chief Medical Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 (view filing) | Aug 29 | 5 days | Smith Thomas BEVP and Chief Medical Officer | SSale | −17.5K | $38.42 | −$671.5K | −19.9%70.3K after | |
| Sep 17, 2024 (view filing) | Sep 13 | 4 days | Smith Thomas BEVP and Chief Medical Officer | SSale | −9.59K | $36.62 | −$351.3K | −15.1%53.8K after | |
| Mar 4, 2024 (view filing) | Feb 29 | 4 days | Smith Thomas BEVP and Chief Medical Officer | SSale | −995 | $36.76 | −$36.6K | −1.5%63.4K after |